Correlation
The correlation between LUNG and NVDA is 0.40, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
LUNG vs. NVDA
Compare and contrast key facts about Pulmonx Corporation (LUNG) and NVIDIA Corporation (NVDA).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: LUNG or NVDA.
Performance
LUNG vs. NVDA - Performance Comparison
Loading data...
Key characteristics
LUNG:
-0.70
NVDA:
0.38
LUNG:
-1.07
NVDA:
0.84
LUNG:
0.87
NVDA:
1.11
LUNG:
-0.60
NVDA:
0.51
LUNG:
-2.01
NVDA:
1.24
LUNG:
28.69%
NVDA:
15.09%
LUNG:
76.87%
NVDA:
58.96%
LUNG:
-95.71%
NVDA:
-89.73%
LUNG:
-95.07%
NVDA:
-9.56%
Fundamentals
LUNG:
$136.88M
NVDA:
$3.39T
LUNG:
-$1.53
NVDA:
$3.01
LUNG:
1.56
NVDA:
22.86
LUNG:
1.66
NVDA:
39.31
LUNG:
$87.47M
NVDA:
$148.52B
LUNG:
$64.37M
NVDA:
$104.12B
LUNG:
-$60.11M
NVDA:
$90.97B
Returns By Period
In the year-to-date period, LUNG achieves a -49.93% return, which is significantly lower than NVDA's 0.63% return.
LUNG
-49.93%
-9.81%
-47.29%
-53.10%
-42.90%
N/A
N/A
NVDA
0.63%
21.07%
-2.24%
23.29%
93.53%
72.51%
74.01%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
LUNG vs. NVDA — Risk-Adjusted Performance Rank
LUNG
NVDA
LUNG vs. NVDA - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Pulmonx Corporation (LUNG) and NVIDIA Corporation (NVDA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Loading data...
Dividends
LUNG vs. NVDA - Dividend Comparison
LUNG has not paid dividends to shareholders, while NVDA's dividend yield for the trailing twelve months is around 0.02%.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
LUNG Pulmonx Corporation | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
NVDA NVIDIA Corporation | 0.02% | 0.02% | 0.03% | 0.11% | 0.05% | 0.12% | 0.27% | 0.46% | 0.29% | 0.45% | 1.20% | 1.70% |
Drawdowns
LUNG vs. NVDA - Drawdown Comparison
The maximum LUNG drawdown since its inception was -95.71%, which is greater than NVDA's maximum drawdown of -89.73%. Use the drawdown chart below to compare losses from any high point for LUNG and NVDA.
Loading data...
Volatility
LUNG vs. NVDA - Volatility Comparison
Pulmonx Corporation (LUNG) has a higher volatility of 33.69% compared to NVIDIA Corporation (NVDA) at 10.81%. This indicates that LUNG's price experiences larger fluctuations and is considered to be riskier than NVDA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading data...
Financials
LUNG vs. NVDA - Financials Comparison
This section allows you to compare key financial metrics between Pulmonx Corporation and NVIDIA Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
LUNG vs. NVDA - Profitability Comparison
LUNG - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2025, Pulmonx Corporation reported a gross profit of 16.34M and revenue of 22.54M. Therefore, the gross margin over that period was 72.5%.
NVDA - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2025, NVIDIA Corporation reported a gross profit of 26.67B and revenue of 44.06B. Therefore, the gross margin over that period was 60.5%.
LUNG - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2025, Pulmonx Corporation reported an operating income of -14.56M and revenue of 22.54M, resulting in an operating margin of -64.6%.
NVDA - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2025, NVIDIA Corporation reported an operating income of 21.64B and revenue of 44.06B, resulting in an operating margin of 49.1%.
LUNG - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2025, Pulmonx Corporation reported a net income of -14.45M and revenue of 22.54M, resulting in a net margin of -64.1%.
NVDA - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2025, NVIDIA Corporation reported a net income of 18.78B and revenue of 44.06B, resulting in a net margin of 42.6%.